This study hypothesized that SCFA, acetate impacts positively on hypothalamic pyroptosis and its related abnormalities in experimentally induced PCOS rat model, possibly through NrF2/HIF1-α modulation. Eight-week-old female Wister rats were divided into groups (n = 5), namely control, PCOS, acetate and PCOS + acetate groups. Induction of PCOS was performed by administering 1 mg/kg body weight of letrozole for 21 days. After PCOS confirmation, the animals were treated with 200 mg/kg of acetate for 6 weeks. Rats with PCOS were characterized with insulin resistance, leptin resistance, increased plasma testosterone as well as degenerated ovarian follicles. There was also a significant increase in hypothalamic triglyceride level, triglyceride-glucose index, inflammatory biomarkers (SDF-1 and NF-kB) and caspase-6 as well as plasma LH and triglyceride. A decrease was observed in plasma adiponectin, GnRH, FSH, and hypothalamic GABA with severe inflammasome expression in PCOS rats. These were accompanied by decreased level of NrF2/HIF1-α, and the alterations were reversed when treated with acetate. Collectively, the present results suggest the therapeutic impact of acetate on hypothalamic pyroptosis and its related comorbidity in PCOS, a beneficial effect that is accompanied by modulation of NrF2/HIF1-α.

Cardio Endo metabolic and Epigenetic Research Unit Department of Physiology College of Medicine and Health Sciences Afe Babalola University P M B 5454 Ado Ekiti 360101 Nigeria

Department of Anatomy College of Medicine and Health Sciences Afe Babalola University Ado Ekiti 360101 Nigeria

Department of Pharmacology and Therapeutics College of Medicine and Health Sciences Afe Babalola University Ado Ekiti 360101 Nigeria

Laboratory of Adipose Tissue Biology Institute of Physiology of the Czech Academy of Sciences Prague Czechia Czechia

Zobrazit více v PubMed

Chen W, Pang Y. Metabolic syndrome and PCOS: Pathogenesis and the role of metabolites. Metabolites. 2021;14(12):869.10.3390/metabo11120869 PubMed DOI PMC

de Melo AS, Dias SV, de Carvalho Cavalli R, Cardoso VC, Bettiol H, Barbieri MA, Ferriani RA, Vieira CS. Pathogenesis of polycystic ovary syndrome: multifactorial assessment from the foetal stage to menopause. Reproduction. 2015;150(1):R11–24. 10.1530/REP-14-0499 PubMed DOI

Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F, Kumar M. Polycystic ovary syndrome: etiology, current management, and future therapeutics. J Clin Med. 2023;12(4):1454. 10.3390/jcm12041454 PubMed DOI PMC

Osibogun O, Ogunmoroti O, Michos ED. Polycystic ovary syndrome and cardiometabolic risk: opportunities for cardiovascular disease prevention. Trends Cardiovasc Med. 2020;30(7):399–404. 10.1016/j.tcm.2019.08.010 PubMed DOI

Liao B, Qiao J, Pang Y. Central regulation of PCOS: abnormal neuronal-reproductive-metabolic circuits in PCOS pathophysiology. Front Endocrinol. 2021;12:667422.10.3389/fendo.2021.667422 PubMed DOI PMC

Rani R, Sharma AK, Chitme HR. Therapeutic effect of Tinospora cordifolia (Willd) extracts on Letrozole-Induced Polycystic Ovarian Syndrome and its complications in Murine Model. Clin Med Insights: Endocrinol Diabetes. 2023;16:p11795514231203864. PubMed PMC

Wang R, Mol BWJ. The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria? Hum Reprod. 2017;32(2):261–4. 10.1093/humrep/dew287 PubMed DOI

Zhou W, Fang F, Zhu W, Chen ZJ, Du Y, Zhang J. 2017. Bisphenol A and ovarian reserve among infertile women with polycystic ovarian syndrome. International journal of environmental research and public health, 14(1), p.18.

Polak K, Czyzyk A, Simoncini T, Meczekalski B. New markers of insulin resistance in polycystic ovary syndrome. J Endocrinol Investig. 2017;40:1–8. 10.1007/s40618-016-0523-8 PubMed DOI PMC

Wang F, Han L, Hu D. Fasting insulin, insulin resistance and risk of hypertension in the general population: a meta-analysis. Clin Chim Acta. 2017;464:57–63. 10.1016/j.cca.2016.11.009 PubMed DOI

Xu J, Dun J, Yang J, Zhang J, Lin Q, Huang M, Ji F, Huang L, You X, Lin Y. Letrozole rat model mimics human polycystic ovarian syndrome and changes in insulin signal pathways. Med Sci Monitor: Int Med J Experimental Clin Res. 2020;26:e923073–1.10.12659/MSM.923073 PubMed DOI PMC

Aflatounian A, Edwards MC, Paris VR, Bertoldo MJ, Desai R, Gilchrist RB, Ledger WL, Handelsman DJ, Walters KA. Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model. J Endocrinol. 2020;245(3):381–95. 10.1530/JOE-19-0530 PubMed DOI

Rose BI, Brown SE. A review of the physiology behind letrozole applications in infertility: are current protocols optimal? J Assist Reprod Genet. 2020;37(9):2093–104. 10.1007/s10815-020-01892-6 PubMed DOI PMC

Varela L, Suyama S, Huang Y, Shanabrough M, Tschöp MH, Gao XB, Giordano FJ, Horvath TL. Endothelial HIF-1α enables hypothalamic glucose uptake to drive POMC neurons. Diabetes. 2017;66(6):1511–20. 10.2337/db16-1106 PubMed DOI PMC

Eepho OI, Bashir AAM, Oniyide AA, Aturamu A, Owolabi OV, Ajadi IO, Fafure AA, Ajadi MB, Areloegbe SE, Olaniyi KS. 2023. Modulation of GABA by sodium butyrate ameliorates hypothalamic inflammation in experimental model of PCOS. BMC neuroscience, 24(1), p.62. PubMed PMC

Wei H, Cui D. Pyroptosis and Insulin Resistance in metabolic organs. Int J Mol Sci. 2022;23(19):11638. 10.3390/ijms231911638 PubMed DOI PMC

Xiang Y, Wang H, Ding H, Xu T, Liu X, Huang Z, Wu H, Ge H. Hyperandrogenism drives ovarian inflammation and pyroptosis: a possible pathogenesis of PCOS follicular dysplasia. Int Immunopharmacol. 2023;125:p111141.10.1016/j.intimp.2023.111141 PubMed DOI

Zheng X, Chen W, Gong F, Chen Y, Chen E. The role and mechanism of pyroptosis and potential therapeutic targets in sepsis: a review. Front Immunol. 2021;12:711939. 10.3389/fimmu.2021.711939 PubMed DOI PMC

Glendining KA, Campbell RE. Recent advances in emerging PCOS therapies. Curr Opin Pharmacol. 2023;68:102345. 10.1016/j.coph.2022.102345 PubMed DOI

Blaak EE, Canfora EE, Theis S, Frost G, Groen AK, Mithieux G, Nauta A, Scott K, Stahl B, Van Harsselaar J, van Tol R. Short chain fatty acids in human gut and metabolic health. Beneficial Microbes. 2020;11(5):411–55. 10.3920/BM2020.0057 PubMed DOI

Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, de Los Reyes-Gavilán CG. Salazar, N. Intestinal short chain fatty acids and their link with Diet and Human Health. Front Microbiol. 2016;17:7:185. PubMed PMC

Miller SJ. Cellular and physiological effects of short-chain fatty acids. Mini Rev Med Chem. 2004;4(8):839–45. 10.2174/1389557043403288 PubMed DOI

Fusco W, Lorenzo MB, Cintoni M, Porcari S, Rinninella E, Kaitsas F, Lener E, Mele MC, Gasbarrini A, Collado MC, Cammarota G. 2023. Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota. Nutrients, 15(9), p.2211. PubMed PMC

Olaniyi KS, Areloegbe SE. 2022. Suppression of PCSK9/NF-kB-dependent pathways by acetate ameliorates cardiac inflammation in a rat model of polycystic ovarian syndrome. Life Sciences, 300, p.120560. PubMed

Olaniyi KS, Areloegbe SE, Oyeleke MB. Acetate restores hypothalamic-adipose kisspeptin status in a rat model of PCOS by suppression of NLRP3 immunoreactivity. Endocrine. 2022;78(3):628–40. 10.1007/s12020-022-03191-9 PubMed DOI

Areloegbe SE, Olaniyi KS. Acetate mitigates cardiac mitochondrial dysfunction in experimental model of polycystic ovarian syndrome by modulating GPCR41/43 and PROKR1. Biochem Biophys Res Commun. 2023;681:62–72. 10.1016/j.bbrc.2023.09.061 PubMed DOI

Olaniyi KS, Owolabi MN, Atuma CL, Agunbiade TB, Alabi BY. Acetate rescues defective brain-adipose metabolic network in obese Wistar rats by modulation of peroxisome proliferator-activated receptor-γ. Sci Rep. 2021;11(1):1–15. 10.1038/s41598-021-98605-5 PubMed DOI PMC

Lee SH, Han K, Yang HK, Kim HS, Cho JH, Kwon HS, Park YM, Cha BY. & Yoon KH 2015 a novel criterion for identifying metabolically obese but normal weight individuals using the product of triglycerides and glucose. Nutr Diabetes 5 e149–156. PubMed PMC

Morigny P, Boucher J, Arner P, Langin D. Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics. Nat Reviews Endocrinol. 2021;17(5):276–95.10.1038/s41574-021-00471-8 PubMed DOI

Namavar Jahromi B, Dabaghmanesh MH, Parsanezhad ME, Fatehpoor F. Association of leptin and insulin resistance in PCOS: a case-controlled study. Int J Reprod Biomed. 2017;15(7):423–8. 10.29252/ijrm.15.7.423 PubMed DOI PMC

Singh S, Akhtar N, Ahmad J. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case–control study. Diabetes Metabolic Syndrome: Clin Res Reviews. 2012;6(4):207–11.10.1016/j.dsx.2012.05.013 PubMed DOI

Reid IR, Baldock PA, Cornish J. Effects of leptin on the skeleton. Endocr Rev. 2018;39(6):938–59. 10.1210/er.2017-00226 PubMed DOI

Tosi F, Negri C, Perrone F, Dorizzi R, Castello R, Bonora E, Moghetti P. Hyperinsulinemia amplifies GnRH agonist stimulated ovarian steroid secretion in women with polycystic ovary syndrome. J Clin Endocrinol. 2012;97(5):1712–9.10.1210/jc.2011-2939 PubMed DOI

Manneras L, Cajander S, Holmäng A, Seleskovic Z, Lystig T, Lönn M, Stener-Victorin E. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology. 2007;148(8):3781–91. 10.1210/en.2007-0168 PubMed DOI

Wang MX, Yin Q, Xu X. A rat model of polycystic ovary syndrome with insulin resistance induced by letrozole combined with high fat diet. Med Sci Monitor: Int Med J Experimental Clin Res. 2020;26:e922136–1. PubMed PMC

Kim JJ, Choi YM. Dyslipidemia in women with polycystic ovary syndrome. Obstet Gynecol Sci. 2013;56(3):137–42. 10.5468/ogs.2013.56.3.137 PubMed DOI PMC

Cohen DE, Fisher EA. November. Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease. Seminars in liver disease. Volume 33. Thieme Medical; 2013. pp. 380–8. 04. PubMed PMC

Cheng L, Yu Y, Szabo A, Wu Y, Wang H, Camer D, Huang XF. Palmitic acid induces central leptin resistance and impairs hepatic glucose and lipid metabolism in male mice. J Nutr Biochem. 2015;26(5):541–8. 10.1016/j.jnutbio.2014.12.011 PubMed DOI

Xu Y, Sheng H, Bao Q, Wang Y, Lu J, Ni X. NLRP3 inflammasome activation mediates estrogen deficiency-induced depression-and anxiety-like behavior and hippocampal inflammation in mice. Brain Behav Immun. 2016;56:175–86. 10.1016/j.bbi.2016.02.022 PubMed DOI

Qiu Z, Lei S, Zhao B, Wu Y, Su W, Liu M, Meng Q, Zhou B, Leng Y, Xia ZY. 2017. NLRP3 inflammasome activation-mediated pyroptosis aggravates myocardial ischemia/reperfusion injury in diabetic rats. Oxidative medicine and cellular longevity, 2017. PubMed PMC

Zheng M, Karki R, Vogel P, Kanneganti TD. Caspase-6 is a key regulator of innate immunity, inflammasome activation, and host defense. Cell. 2020;181(3):674–87. 10.1016/j.cell.2020.03.040 PubMed DOI PMC

Kesavardhana S, Malireddi RS, Kanneganti TD. Caspases in cell death, inflammation, and pyroptosis. Annu Rev Immunol. 2020;38:567–95. 10.1146/annurev-immunol-073119-095439 PubMed DOI PMC

Yan J, Zhang Z, Shi H. HIF-1 is involved in high glucose-induced paracellular permeability of brain endothelial cells. Cell Mol Life Sci. 2012;69:115–28. 10.1007/s00018-011-0731-5 PubMed DOI PMC

Wang C, Wei S, Liu B, Wang F, Lu Z, Jin M, Wang Y. Maternal consumption of a fermented diet protects offspring against intestinal inflammation by regulating the gut microbiota. Gut Microbes. 2022;14(1):2057779. 10.1080/19490976.2022.2057779 PubMed DOI PMC

Cosin-Roger J, Simmen S, Melhem H, Atrott K, Frey-Wagner I, Hausmann M, de Vallière C, Spalinger MR, Spielmann P, Wenger RH, Zeitz J. Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation. Nat Commun. 2017;8(1):98. 10.1038/s41467-017-00213-3 PubMed DOI PMC

Thaler JP, Guyenet SJ, Dorfman MD, Wisse BE, Schwartz MW. Hypothalamic inflammation: marker or mechanism of obesity pathogenesis? Diabetes. 2013;62(8):2629–34. 10.2337/db12-1605 PubMed DOI PMC

Tang X, Jaenisch R, Sur M. The role of GABAergic signalling in neurodevelopmental disorders. Nat Rev Neurosci. 2021;22(5):290–307. 10.1038/s41583-021-00443-x PubMed DOI PMC

Chaudhari N, Dawalbhakta M, Nampoothiri L. GnRH dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile. Reproductive Biology Endocrinol. 2018;16:1–13.10.1186/s12958-018-0354-x PubMed DOI PMC